Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine.
Eur J Neurol. 2024 Apr;31(4):e16203. doi: 10.1111/ene.16203. Epub 2024 Jan 25.
Eur J Neurol. 2024.
PMID: 38270379
Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study.
Gago-Veiga AB, Lopez-Alcaide N, Quintas S, Fernández Lázaro I, Casas-Limón J, Calle C, Latorre G, González-García N, Porta-Etessam J, Rodriguez-Vico J, Jaimes A, Gómez García A, García-Azorín D, Guerrero-Peral ÁL, Sierra Á, Lozano Ros A, Sánchez-Soblechero A, Díaz-de-Teran J, Membrilla JA, Treviño C, Gonzalez-Martinez A.
Gago-Veiga AB, et al.
Eur J Neurol. 2024 May;31(5):e16215. doi: 10.1111/ene.16215. Epub 2024 Feb 7.
Eur J Neurol. 2024.
PMID: 38323742
Item in Clipboard
Cite
Cite